Deals & More: VillageVines grabs $3M so foodies can dine with discounts, EndoSphere gets $1.3M to help you slim down

Today’s funding announcements include one company that encourages you to eat and another that helps you lose weight:

VillageVines gobbles up $3M for affordable upscale dining: The New York-based startup has raised a first round of funding from Hearst Interactive Media, GrandBanks Capital and High Peaks Venture Partners for its exclusive restaurant site. The site, which launched eight months ago, offers diners discounted restaurant reservations (typically 30 percent off the entire bill) in New York, San Francisco, Los Angeles, Chicago and Washington, D.C.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":236880,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"entrepreneur,","session":"B"}']

EndoSphere grabs $1.3M to treat metabolic diseases: The medical device maker has raised $1.3M of an expected $5.1M in equity funding to treat obesity and type 2 diabetes, according to a filing with the SEC. The company, which recently moved from Redwood City, Calif. to Columbus, Ohio, has developed a temporary implant that, when placed in the small intestine, helps patients lose weight by slowing the passage of food.

SCHAD raises $4.2M so engineers can manage facilities on the go: The Hamburg, Germany-based company has raised a funding round led by M8 Capital for its mobile technology. Using SCHAD’s product, engineers can remotely access and manage company plants from mobile phones and mobile devices. The company, which works with clients like Ford and Volkswagen, plans to use its funding for global expansion.

Neuroptix brings in $4M to detect Alzheimer’s Disease: The Acton, Mass.-based company has raised funding in its third round led by Swiss investor Inventages Venture Capital, peHUB reports. The company, which plans to use the funding to continue clinical development, is developing a non-invasive laser eye scanning test for early detection and diagnosis of Alzheimer’s Disease.